Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pituitary Neoplasms 7 Neuroendocrine Tumors 6 Carcinoid Tumor 5 Acromegaly 5 Prostatic Neoplasms 4 Pancreatic Neoplasms 4 Gastro-enteropancreatic neuroendocrine tumor 3 Pituitary ACTH Hypersecretion 2 Neoplasms 2 Neoplasm Metastasis 2 Nelson Syndrome 2 Multiple Myeloma 2 Liver Neoplasms 2 Growth Disorders 2 Gigantism 2 Carcinoma, Intraductal, Noninfiltrating 2 Carcinoma, Hepatocellular 2 ACTH Syndrome, Ectopic 2 Uveal Melanoma 1 Thyroid Neoplasms 1 Small Cell Lung Carcinoma 1 Serotonin Syndrome 1 Sarcoma, Synovial 1 Prolactinoma 1 Prolactin-Producing Pituitary Tumor 1 Primary Inoperable Thymoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Peritoneal Neoplasms 1 Pancreatic Fistula 1 Neuroectodermal Tumors, Primitive 1

Interventions

Hyperthermic Intraperitoneal Chemotherapy 28 Paclitaxel 24 Cisplatin 23 Oxaliplatin 18 Cytoreduction Surgical Procedures 17 Carboplatin 17 Fluorouracil 14 Bevacizumab 10 Mitomycin 9 Leucovorin 9 Doxorubicin 9 Docetaxel 6 Gemcitabine 5 130-nm albumin-bound paclitaxel 5 Surgical Procedures, Operative 4 Neoadjuvant Therapy 4 Blood Specimen Collection 4 Albumin-Bound Paclitaxel 4 sodium thiosulfate 3 liposomal doxorubicin 3 catumaxomab 3 Taxes 3 Laparoscopy 3 Drug Therapy 3 Chemotherapy, Adjuvant 3 tremelimumab 2 relacorilant 2 pembrolizumab 2 olaparib 2 nintedanib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Peritoneal Neoplasms × pasireotide × Clear all

NCT04826432 2024-02-08

PASIREOCHIP

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2 Terminated

Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡